Roivant’s Anti-inflammatory Drug Succeeds in Mid-stage Study

Roivant Sciences said on Tuesday its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending...
Reuters Health Information

Full Story →